HD

344.11

-0.63%↓

TJX

153.64

-1.09%↓

LOW

241.16

-0.84%↓

NKE

63.74

+4.17%↑

ROST

180.21

-0.72%↓

HD

344.11

-0.63%↓

TJX

153.64

-1.09%↓

LOW

241.16

-0.84%↓

NKE

63.74

+4.17%↑

ROST

180.21

-0.72%↓

HD

344.11

-0.63%↓

TJX

153.64

-1.09%↓

LOW

241.16

-0.84%↓

NKE

63.74

+4.17%↑

ROST

180.21

-0.72%↓

HD

344.11

-0.63%↓

TJX

153.64

-1.09%↓

LOW

241.16

-0.84%↓

NKE

63.74

+4.17%↑

ROST

180.21

-0.72%↓

HD

344.11

-0.63%↓

TJX

153.64

-1.09%↓

LOW

241.16

-0.84%↓

NKE

63.74

+4.17%↑

ROST

180.21

-0.72%↓

Search

Vestis Corp

Gesloten

SectorConsumenten cyclisch

6.7 -1.33

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

6.63

Max

6.75

Belangrijke statistieken

By Trading Economics

Inkomsten

-12M

-13M

Verkoop

38M

712M

EPS

-0.095

Dividendrendement

1.95

Winstmarge

-1.762

Werknemers

18,150

EBITDA

-7.8M

49M

Aanbevelingen

By TipRanks

Aanbevelingen

Sell

12 Maanden Prognose

-12.11% downside

Dividenden

By Dow Jones

Dividendrendement

Sectorgemiddelde

1.95%

2.93%

Marktinformatie

By TradingEconomics

Marktkapitalisatie

-80M

705M

Vorige openingsprijs

8.03

Vorige sluitingsprijs

6.7

Nieuwssentiment

By Acuity

50%

50%

120 / 370 Rangschikking in Consumer cyclical

Vestis Corp Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

31 dec 2025, 22:20 UTC

Belangrijke Marktbewegers

Outlook Therapeutics Shares Fall After Another FDA Rejection of Macular Degeneration Drug

31 dec 2025, 17:31 UTC

Belangrijke Marktbewegers

OwlTing Climbs on Launch of $10 Million Stock-Buyback Program

31 dec 2025, 16:30 UTC

Belangrijke Marktbewegers

Trump Media Gains on Plan to Distribute Digital Tokens to Shareholders

31 dec 2025, 15:19 UTC

Belangrijke Marktbewegers

Axsome Shares Climb on FDA Fast‑Track for Alzheimer's Drug, Backing for Narcolepsy Filing

31 dec 2025, 15:17 UTC

Belangrijke Marktbewegers

Nike Shares Rise After CEO Hill Buys $1 Million of Shares

31 dec 2025, 14:37 UTC

Belangrijke Marktbewegers

Corcept Shares Fall as FDA Requires More Evidence for Hypercortisolism Drug Application

1 jan 2026, 23:35 UTC

Marktinformatie

Gold Rises Amid Geopolitical Risks -- Market Talk

1 jan 2026, 21:29 UTC

Acquisities, Fusies, Overnames

BlueScope: Transaction Completed on Terms Agreed When Deal Announced on Nov 13

1 jan 2026, 21:29 UTC

Acquisities, Fusies, Overnames

BlueScope Sold Stake in JV to Tata Steel

1 jan 2026, 21:28 UTC

Acquisities, Fusies, Overnames

BlueScope Steel Says Sale of Stake in Tata BlueScope Steel Completed on Dec 31

1 jan 2026, 17:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

1 jan 2026, 09:20 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

31 dec 2025, 21:50 UTC

Marktinformatie

Basic Materials Roundup: Market Talk

31 dec 2025, 21:13 UTC

Acquisities, Fusies, Overnames

10 People to Watch in Wealth Management in 2026 -- Barrons.com

31 dec 2025, 20:40 UTC

Marktinformatie

Dollar Posting Its Worst Year Since 2017 -- Market Talk

31 dec 2025, 20:22 UTC

Marktinformatie

Oil Posts Loss in a Year Marked By Plentiful Supply -- Market Talk

31 dec 2025, 19:50 UTC

Marktinformatie

U.S. Natural Gas Futures Sink on Weather Outlook -- Market Talk

31 dec 2025, 19:31 UTC

Marktinformatie

Precious Metals Cap Off Record Runs -- Market Talk

31 dec 2025, 18:50 UTC

Marktinformatie

Global Equities Roundup: Market Talk

31 dec 2025, 18:50 UTC

Marktinformatie

Canadian Gold Miners Enjoy a Bumper Year in 2025 -- Market Talk

31 dec 2025, 17:17 UTC

Marktinformatie

U.S. Natural Gas Inventories Fall Less Than Expected -- Market Talk

31 dec 2025, 17:16 UTC

Belangrijke Marktbewegers

OwlTing Climbs on Launch of $10M Stock-Buyback Program

31 dec 2025, 17:15 UTC

Marktinformatie

Global Commodities Roundup: Market Talk

31 dec 2025, 17:00 UTC

Acquisities, Fusies, Overnames

Nvidia Is Getting Creative as Options to Use Its Cash Flood Narrow -- Heard on the Street -- WSJ

31 dec 2025, 15:57 UTC

Acquisities, Fusies, Overnames

Vanda Pharmaceuticals Shares Jump 30% on Motion Sickness Drug Approval -- Barrons.com

31 dec 2025, 15:54 UTC

Marktinformatie

Layoff Data Supports Dollar at End of Losing Year -- Market Talk

31 dec 2025, 15:02 UTC

Belangrijke Marktbewegers

Nike Shares Rise After CEO Hill Buys $1M of Shares

31 dec 2025, 14:40 UTC

Acquisities, Fusies, Overnames

Nike CEO Buys $1 Million of Stock as Insiders Bet on a Turnaround -- Barrons.com

31 dec 2025, 14:20 UTC

Marktinformatie

Crude Futures On Track to End the Year With Losses -- Market Talk

31 dec 2025, 13:46 UTC

Marktinformatie

U.S. Natural Gas Falls on Milder Weather Outlook -- Market Talk

Peer Vergelijking

Prijswijziging

Vestis Corp Prognose

Koersdoel

By TipRanks

-12.11% neerwaarts potentieel

12 Maanden Prognose

Gemiddelde 5.95 USD  -12.11%

Hoogste 6.5 USD

Laagste 5 USD

Gebaseerd op 5 Wall Street-analisten die 12-maands prijsdoelen bieden voor Vestis Corp - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Sell

5 ratings

0

Buy

3

Hold

2

Sell

Sentiment

By Acuity

120 / 370 Rangschikking in Consumenten cyclisch

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

help-icon Live chat